(Q41563534)

3 October 2017

1 reference

title

Anti-gene therapy: the use of ribozymes to inhibit gene function (English)

1 reference

3 October 2017

0 references

0 references

2

1 reference

3 October 2017

Couture LA

1

1 reference

3 October 2017

publication date

1 December 1996

1 reference

3 October 2017

1 reference

3 October 2017

volume

12

1 reference

3 October 2017

issue

12

1 reference

3 October 2017

page(s)

510-515

1 reference

Ribozymes as human therapeutic agents

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozymes: biology, biochemistry, and implications for clinical medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Inhibition of gene expression with ribozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Construction and characterization of lck- and fyn-specific tRNA: ribozyme chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Activation of HIV-specific ribozyme activity by self-cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozyme-Mediated Cleavage of an HIV-1gagRNA: The Effects of Nontargeted Sequences and Secondary Structure on Ribozyme Cleavage Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Can hammerhead ribozymes be efficient tools to inactivate gene function?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

The fowl adenovirus type 1 (CELO) virus-associated RNA-encoding gene: a new ribozyme-expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Colocalizing ribozymes with substrate RNAs to increase their efficacy as gene inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozymes as potential anti-HIV-1 therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozyme mediated destruction of influenza A virus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2897%2981398-4

7 January 2021

10.1016/S0168-9525(97)81398-4

Identifiers

DOI

1 reference

3 October 2017

1 reference